Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Felipe C. Albuquerque has a total of 240 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparison of nBCA and Onyx for Embolization of Spinal Dural Arteriovenous Fistulas

    by Jacob F. Baranoski, Joshua S. Catapano, Caleb Rutledge, Tyler S. Cole, Neil Majmundar, Benjamin K. Hendricks, D. Andrew Wilkinson, Daniel D. Cavalcanti, Alfred P. See, Bruno C. Flores, et al.

    Background: Endovascular embolization can effectively treat spinal dural arteriovenous fistulas (SDAVFs). One factor limiting the success and durability of endovascular treatments is reliably casting and occluding the draining vein. We sought to compare the efficacies of n ‐butyl‐2‐cyanoacrylate (nBCA) and Onyx in the treatment of SDAVFs. Methods: We retrospectively analyzed patients with SDAVFs treated with endovascular embolization for whether a “durable cure” was achieved, defined as complete obliteration, clinical improvement, and sustained radiologic cure on follow‐up. We compared the outcomes of patients treated with Onyx to those treated with nBCA. Results: A total of 40 embolizations for SDAVFs were performed in 38 patients. All patients were treated exclusively with liquid embolysates: Onyx alone (n = 22), nBCA alone (n = 16), or nBCA and Onyx combined (n = 2). For 45% (10/22) of patients treated with Onyx only, complete obliteration of the fistula with casting of the vein was not achieved. These patients were referred for microsurgical ligation. For all 16 patients treated with nBCA only, complete obliteration of the fistula was achieved. All 16 patients exhibited a durable cure compared with 11 of 22 patients (50%) in the Onyx‐only group ( P = 0.002). Conclusion: nBCA may be superior to Onyx for the embolization of SDAVFs. nBCA embolization is safe and effective for a subset of SDAVFs. Prospective studies comparing SDAVF treatment strategies are warranted.


  • Open Access

    E-165 Treatment of intraorbital arteriovenous fistulas with direct puncture: a case series and review oof treatments since 1978

    by S Pathuri, W Johnson, K Russell, A Robledo, F Albuquerque, P Kan, J Mascitelli

    Introduction/Purpose Intraorbital Arteriovenous Fistulas (IOAVFs) are a rare entity often misdiagnosed initially as carotid cavernous fistulas (CCFs). Although patients present in similar fashion and they appear angiographically similar, the diagnosis is differentiated by the location of the fistulous point within the orbit rather than posteriorly in the cavernous sinus. Like other dAVFs, treatments include observation, transarterial embolization (TAE), transvenous embolization (TVE), surgical disconnection, or combination of multiple approaches. There have only been a few previous reports utilizing direct puncture (DP) to treat these lesions. We present a series of 3 unique cases of DP with TVE and a review of the literature from 1978. Methods The presenting symptoms, treatment and outcome are all described. A literature review is performed back to 1978. Results All 3 patients presented with classic symptoms (proptosis, chemosis, and extra-ocular movement restriction). All 3 patients were ultimately cured using a direct puncture (DP) and venous embolization. Patient 1 underwent two procedures: an incomplete transfemoral/TAE through the ECA followed by a successful DP/TVE with coils/Onyx utilizing an enlarged vein in the eyelid. The patient suffered an intra-orbital hematoma during the DP requiring a lateral canthotomy (LC). Patient 2 also underwent two procedures: an unsuccessful transfemoral TVE followed by a DP/TVE with Onyx utilizing a sub-ciliary incision and puncture along the inferior orbital rim. Patient 2 also suffered an orbital hematoma requiring an endoscopic/endonasal evacuation from the medial orbit. Patient 3 underwent one procedure: a failed DP attempt and then a successful DP after three-dimensional angiographic guidance in the same setting. The patient was treated curatively after the second successful direct puncture. All patients were angiographically cured and have had resolution of orbital symptoms with normal vision. Our survey of the literature revealed 49 total cases of IOAVFs of which 17 were managed conservatively, 8 underwent transarterial embolization, 18 underwent transvenous embolization, and 5 underwent percutaneous punctures. Conservative management and transarterial treatments resulted in the worst outcomes with 23.5% and 37.5% of patients with worsened visual function respectively. Conclusions IOAVFs present similarly to CCFs but have slightly different angiographic anatomy. Like other dAVFs, IOAVFs frequently will require multiple treatments, but DP appears to be a reasonable option for obtaining a cure. Orbital hematoma is not infrequent, and awareness/preparation for a secondary procedure (e.g., LC) is important to preserve vision. Disclosures S. Pathuri: None. W. Johnson: None. K. Russell: None. A. Robledo: None. F. Albuquerque: None. P. Kan: None. J. Mascitelli: None.

  • Open Access

    E-234 Prevalence and predictors of brachioradial artery anatomy in neurointerventional procedures

    by J Catapano, J Rulney, A Naik, S Koester, V Srinivasan, S Desai, E Winkler, A Jadhav, A Ducruet, F Albuquerque

    Background Trans-radial artery (TRA) access for neurointerventional procedures continues to garner increase usage among interventionalist. While TRA approaches are associated with a decreased risk of major access site complications, such issues can occur with a retained catheter, one of the most dreaded complications. Previously, the brachioradial artery (BR), specifically proximal BR, has been postulated to be associated with a retained catheter. Herein, the prevalence and predictors of BR in neurointerventional procedures is investigated in a large quaternary center. Methods All patients who underwent a neurointerventional procedure during a 13-month period were retrospectively analyzed for a TRA approach and included in the study. Distal BR were defined as 10-20 cm proximal to the intercondylar line, with proximal BR defined as >20 cm. A multivariable logistic regression analysis was performed for predictor of a BR. Results During the study period, 751 patients were found to meet inclusion criteria and analyzed. Of these patients, 51 (6.8%) had proximal or distal BR, of which 36 (4.8%) had proximal origins. On multivariate analysis, it was found that females (OR = 2.5 (95% CI: 1.1 - 6.1), p = 0.026) and Black patients (OR = 12.3 (95% CI: 2.0 - 62.4), p = 0.01) were more likely to have a proximal BR. Radial artery diameter was not a predictor for a BR. However, female patients were associated with smaller diameters (Conclusion The brachioradial artery variant is found in nearly 7% of patients undergoing a neurointerventional procedures, with Black race and female gender found to be predictors of proximal BR origin. Thus, appropriate vigilance is required when treating these demographics for a neurointervention. Disclosures J. Catapano: None. J. Rulney: None. A. Naik: None. S. Koester: None. V. Srinivasan: None. S. Desai: None. E. Winkler: None. A. Jadhav: None. A. Ducruet: None. F. Albuquerque: None. F. Albuquerque: None.

  • Endovascular Treatment of Cerebrovascular Lesions Using Nickel- or Nitinol-Containing Devices in Patients with Nickel Allergies

    by J.F. Baranoski, J.S. Catapano, C. Rutledge, T.S. Cole, N. Majmundar, E.A. Winkler, V.M. Srinivasan, A.P. Jadhav, A.F. Ducruet, F.C. Albuquerque

    SUMMARY: Nickel is used in many cerebral endovascular treatment devices. However, nickel hypersensitivity is the most common metal allergy, and the relative risk of treatment in these patients is unknown. This retrospective analysis identified patients with nickel or metal allergies who underwent cerebral endovascular treatment with nickel-containing devices. Seven patients with nickel and/or other metal allergies underwent treatment with 9 nickel-containing devices. None experienced periprocedural complications. No patient received treatment with corticosteroids or antihistamines. At a mean clinical follow-up for all patients of 22.8 months (range, 10.5–38.0 months), no patients had symptoms attributable to nickel allergic reactions. The mean radiographic follow-up for all patients at 18.4 months (range, 2.5–37.5 months) showed successful treatment of the targeted vascular pathologies, with no evidence of in-stent stenosis or other allergic or hypersensitivity sequelae. The treatment of cerebrovascular lesions with a nickel-containing device resulted in no adverse outcomes among these patients and was safe and effective.


  • Outcomes in Patients with Aneurysmal Subarachnoid Hemorrhage Receiving Sulfonylureas: A Propensity-Adjusted Analysis

    by Joshua S. Catapano, Stefan W. Koester, Kamila M. Bond, Visish M. Srinivasan, Dara S. Farhadi, Kavelin Rumalla, Tyler S. Cole, Jacob F. Baranoski, Ethan A. Winkler, Christopher S. Graffeo, et al.


  • Open Access

    Reply:

    by L. Scherschinski, J.S. Catapano, A.P. Jadhav, A.F. Ducruet, F.C. Albuquerque

  • Incidence and Prediction of Chronic Depression Following Aneurysmal Subarachnoid Hemorrhage: A Single-Center 17-Year Experience

    by Joshua S. Catapano, Kavelin Rumalla, Stefan W. Koester, Ethan A. Winkler, Robert F. Rudy, Tyler S. Cole, Jacob F. Baranoski, Christopher S. Graffeo, Visish M. Srinivasan, Ruchira M. Jha, et al.


  • The Woven EndoBridge (WEB) Device for the Treatment of Intracranial Aneurysms: Ten Years of Lessons Learned and Adjustments in Practice from the WorldWideWEB Consortium

    by Adam A. Dmytriw, Mahmoud Dibas, Sherief Ghozy, Nimer Adeeb, Jose Danilo Bengzon Diestro, Kevin Phan, Hugo H. Cuellar-Saenz, Ahmad Sweid, Sovann V. Lay, Adrien Guenego, et al.

    Several studies have shown promising outcomes of the Woven EndoBridge (WEB) device for the treatment of wide-necked intracranial bifurcation aneurysms. This is a multicenter study attempts to explore the changes in trends and treatment outcomes over time for WEB embolization of intracranial aneurysms. The WorldWideWEB consortium is a retrospective multicenter collaboration of data from international centers spanning from January 2011 and June 2021, with no limitations on aneurysm location or rupture status. Both bifurcation and sidewall aneurysms were included. These patients were stratified based on treatment year into five treatment intervals: 2011–2015 (N = 66), 2016–2017 (N = 77), 2018 (N = 66), 2019 (N = 300), and 2020–2021 (N = 173). Patient characteristics and angiographic and clinical outcomes were compared between these time intervals. This study comprised 671 patients (median age 61.4 years; 71.2% female) with 682 intracranial aneurysms. Over time, we observed an increasing tendency to treat patients presenting with ruptured aneurysms and aneurysms with smaller neck, diameter, and dome widths. Furthermore, we observed a trend towards more off-label use of the WEB for sidewall aneurysms and increased adoption of transradial access for WEB deployment. Moreover, the proportion of patients with adequate WEB occlusion immediately and at last follow-up was significantly higher in more recent year cohorts, as well as lower rates of compaction and retreatment. Mortality and complications did not differ over time. This learning curve study suggests improved experience using the WEB for the treatment of intracranial aneurysms and has yielded higher rates of adequate occlusion over time.


  • Liver Cirrhosis and Inpatient Mortality in Aneurysmal Subarachnoid Hemorrhage: A Propensity-Adjusted Analysis

    by Joshua S. Catapano, Katriel E. Lee, Kavelin Rumalla, Visish M. Srinivasan, Tyler S. Cole, Jacob F. Baranoski, Ethan A. Winkler, Christopher S. Graffeo, Muhaiman Alabdly, Ruchira M. Jha, et al.


  • Health Care Expenditures Associated with Delayed Cerebral Ischemia Following Subarachnoid Hemorrhage: A Propensity-Adjusted Analysis

    by Stefan W. Koester, Joshua S. Catapano, Kavelin Rumalla, Stephen J. Dabrowski, Dimitri Benner, Ethan A. Winkler, Tyler S. Cole, Jacob F. Baranoski, Visish M. Srinivasan, Christopher S. Graffeo, et al.